![Timothy Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Smith
Investor Relations Kontakt bei
PMV PHARMACEUTICALS, INC.
Profil
Timothy J.
Smith is currently Head-Corporate Development & Investor Relations at PMV Pharmaceuticals, Inc. since 2021.
Former positions include Chief Business Officer at Verseau Therapeutics, Inc. from 2019 to 2021; Executive Director-Global Business Planning at Celgene Corp.
from 2013 to 2016; Senior Director-Investor Relations at MGI PHARMA, Inc.; Chief Business Officer at Cleave Therapeutics, Inc.; and Senior Vice President & Head-Corporate Development at Celgene Corp.
Education includes graduate studies at The Trustees of Columbia University in The City of New York, an MBA from Fordham University, and undergraduate studies at The University of Texas at Arlington.
Aktive Positionen von Timothy Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Timothy Smith
| Unternehmen | Position | Ende |
|---|---|---|
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Corporate Officer/Principal | 01.03.2021 |
| CELGENE | Investor Relations Kontakt | 03.01.2012 |
| CELGENE | Corporate Officer/Principal | - |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Corporate Officer/Principal | - |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Investor Relations Kontakt | - |
Ausbildung von Timothy Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Commercial Services |
Wählen Sie MarketScreener 
